Cargando…
Loss of CDKN1A mRNA and Protein Expression Are Independent Predictors of Poor Outcome in Chromophobe Renal Cell Carcinoma Patients
Chromophobe renal cell carcinoma (chRCC) patients have good prognosis. Only 5%–10% patients die of metastatic disease after tumorectomy, but tumor progression cannot be predicted by histopathological parameters alone. chRCC are characterized by losses of many chromosomes, whereas gene mutations are...
Autores principales: | Ohashi, Riuko, Angori, Silvia, Batavia, Aashil A., Rupp, Niels J., Ajioka, Yoichi, Schraml, Peter, Moch, Holger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072616/ https://www.ncbi.nlm.nih.gov/pubmed/32079343 http://dx.doi.org/10.3390/cancers12020465 |
Ejemplares similares
-
Allele Loss and Reduced Expression of CYCLOPS Genes is a Characteristic Feature of Chromophobe Renal Cell Carcinoma
por: Ohashi, Riuko, et al.
Publicado: (2019) -
Classic Chromophobe Renal Cell Carcinoma Incur a Larger Number of Chromosomal Losses Than Seen in the Eosinophilic Subtype
por: Ohashi, Riuko, et al.
Publicado: (2019) -
Next Generation Sequencing of Reactive Stroma and Residual Breast Cancer Cells in Tumor Bed after Neoadjuvant Chemotherapy
por: Varga, Zsuzsanna, et al.
Publicado: (2022) -
Spatial Distribution of Private Gene Mutations in Clear Cell Renal Cell Carcinoma
por: Moore, Ariane L., et al.
Publicado: (2021) -
The Morphological Spectrum of Papillary Renal Cell Carcinoma and Prevalence of Provisional/Emerging Renal Tumor Entities with Papillary Growth
por: Lobo, João, et al.
Publicado: (2021)